Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer
Jennifer Y. Ge(Harvard University), Kornélia Polyák(Dana-Farber Cancer Institute), David Pellman(Broad Institute), Anne Trinh(Brigham and Women's Hospital), Kai W. Wucherpfennig(Dana-Farber Cancer Institute), Bojana Jovanović(Harvard University), Anushree C. Gulvady(Harvard University), Myles Brown(Harvard University), Adrienne Luoma(Harvard University), Anne Fassl(Harvard University), Aaron R. Thorner(Center for Cancer Research), Thomas O. McDonald(Harvard University), Cloud P. Paweletz(Massachusetts General Hospital), Grace A. Heavey(Dana-Farber Cancer Institute), Jun Qi(Georgia Institute of Technology), Piotr Siciński(Harvard University), Katherine C. Murphy(Dana-Farber Cancer Institute), Shaokun Shu(Peking University), Mijung Kwon(Harvard University), Yanan Kuang(Dana-Farber Cancer Institute)
Cited by 97
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k
The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k